Skip to main content

Cannaisseur Group Inc.

corporate_fare Company Profile

Cannaisseur Group Inc.

TCRG·OTC·Life Sciences·CIK 0001879270

The Cannaisseur Group, Inc. (TCRG) is a Delaware corporation established in December 2020, which has transitioned into a health and wellness company. Its current operations consist solely of a 51% interest in Atlanta CBD Inc., acquired on January 4, 2021. TCRG manages and operates Atlanta CBD's business daily. Atlanta CBD, a Georgia company founded in October 2018, initially engaged in hemp cultivation, extraction, manufacturing, distribution, and retail sales of hemp products under the trade name Inno Medicinals in Atlanta, Georgia. Reflecting TCRG's strategic shift, Atlanta CBD now intends to sell health and wellness products through its retail operations. TCRG plans to expand its health and wellness business by acquiring assets such as CBD cultivation, processing, and distribution equipment and infrastructure from companies that grow and develop CBD and other health-related products for the consumer market. These acquisitions will support both TCRG's growth and Atlanta CBD's operations. TCRG intends to use a combination of equity (common stock) and funds from private placements to acquire these assets.

Cannaisseur Group Inc. (OTC:TCRG) is a publicly traded company in the Life Sciences sector. Wiseek monitors TCRG SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Cannaisseur Group Reports Near-Zero Cash, Ineffective Controls, and Reaffirms Going Concern
  • Cannaisseur Group Faces Going Concern, Zero Revenue, and Massive Dilution Amid Risky Acquisition

monitoring Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$0
Net Income
-$1.77M
Diluted EPS
-$0.03
Op. Cash Flow
-$127.45K
Gross Profit
-$910
Operating Income
-$1.72M
Cash & Equivalents
$22
Debt / Equity
0.00×
Shares Outstanding
60.46M sh
Source: 10-K · filed 2026-03-23 · accession 0001185185-26-001012

supervised_user_circle Insider Transactions

  • 2025-07-23 Balencic Jordan Paul Director
    Grant/Award 1.5M sh $408.6K @ $0.27
  • 2025-07-23 Gogo Floretta CEO Officer · Director
    Grant/Award 1M sh $10K @ $0.01
  • 2025-07-23 Xavier Carter CFO Officer · Director
    Grant/Award 1M sh $272.4K @ $0.27
  • 2025-07-23 Brown Jamie Lee COO Officer · Director
    Grant/Award 500K sh $136.2K @ $0.27
From SEC Form 4 + 5 (insider beneficial-ownership filings) · last 12 months · view all on SEC EDGAR ↑
$0.75
52-week range $0.01 – $2.99
Volume
300 (0.0× avg)
3-mo avg 7.7K
Price snapshot as of 2026-05-22 01:53 UTC (Market snapshot (OVERNIGHT))

show_chartPrice Chart

Loading chart...

feed TCRG - Latest Insights

TCRG
May 08, 2026, 5:32 PM EDT
Filing Type: 10-Q
Importance Score:
9
TCRG
Mar 23, 2026, 1:13 PM EDT
Filing Type: 10-K
Importance Score:
9